Search

Your search keyword '"Du QS"' showing total 80 results

Search Constraints

Start Over You searched for: Author "Du QS" Remove constraint Author: "Du QS"
80 results on '"Du QS"'

Search Results

51. Textilinin-1, an alternative anti-bleeding agent to aprotinin: Importance of plasmin inhibition in controlling blood loss.

52. Physics and chemistry-driven artificial neural network for predicting bioactivity of peptides and proteins and their design.

53. Fragment-based quantitative structure-activity relationship (FB-QSAR) for fragment-based drug design.

54. An in-depth analysis of the biological functional studies based on the NMR M2 channel structure of influenza A virus.

55. Molecular potential energies in dodecahedron cell of methane hydrate and dispersion correction for DFT.

56. Recent advances in QSAR and their applications in predicting the activities of chemical molecules, peptides and proteins for drug design.

57. Localization and visualization of excess chemical potential in statistical mechanical integral equation theory 3D-HNC-RISM.

58. Multiple field three dimensional quantitative structure-activity relationship (MF-3D-QSAR).

59. Analogue inhibitors by modifying oseltamivir based on the crystal neuraminidase structure for treating drug-resistant H5N1 virus.

60. Peptide reagent design based on physical and chemical properties of amino acid residues.

61. Predicting the affinity of epitope-peptides with class I MHC molecule HLA-A*0201: an application of amino acid-based peptide prediction.

62. DCL4 targets Cucumber mosaic virus satellite RNA at novel secondary structures.

63. Empirical Correction to Molecular Interaction Energies in Density Functional Theory (DFT) for Methane Hydrate Simulation.

64. Virtual screening for finding natural inhibitor against cathepsin-L for SARS therapy.

65. Study of drug resistance of chicken influenza A virus (H5N1) from homology-modeled 3D structures of neuraminidases.

66. Myosin X regulates netrin receptors and functions in axonal path-finding.

67. Inhibitor design for SARS coronavirus main protease based on "distorted key theory".

68. Anti-SARS drug screening by molecular docking.

69. Insights from modeling the 3D structure of H5N1 influenza virus neuraminidase and its binding interactions with ligands.

70. Amino Acid Principal Component Analysis (AAPCA) and its applications in protein structural class prediction.

71. Molecular modeling studies of peptide drug candidates against SARS.

72. Heuristic molecular lipophilicity potential (HMLP): lipophilicity and hydrophilicity of amino acid side chains.

73. [Screening of new HIV inhibitors based on the database of traditional Chinese medicine].

74. Progress in computational approach to drug development against SARS.

75. Theoretical studies of Alzheimer's disease drug candidate 3-[(2,4-dimethoxy)benzylidene]-anabaseine (GTS-21) and its derivatives.

76. Polyprotein cleavage mechanism of SARS CoV Mpro and chemical modification of the octapeptide.

77. Regulation of the formation of osteoclastic actin rings by proline-rich tyrosine kinase 2 interacting with gelsolin.

78. Inhibition of PYK2-induced actin cytoskeleton reorganization, PYK2 autophosphorylation and focal adhesion targeting by FAK.

79. Regulation of CDC42 GTPase by proline-rich tyrosine kinase 2 interacting with PSGAP, a novel pleckstrin homology and Src homology 3 domain containing rhoGAP protein.

80. Regulation of neuregulin signaling by PSD-95 interacting with ErbB4 at CNS synapses.

Catalog

Books, media, physical & digital resources